Meridian Says FDA Clears New Bacterial Test
Meridian says FDA clears new bacterial test
Published Date: December 27, 2011 02:18:00 PM EST
CINCINNATI (AP) Meridian Biosciences Inc. said Tuesday that regulators cleared a new test for clostridium difficile, a bacterium that can cause diarrhea and colon inflammation.
Meridian said its new ImmunoCard C. difficile GDH test detects a common antigen to the bacterium. Patients who test positive for the antigen can then be screened with a more sensitive test. Meridian also sells a C. difficile test called illumigene.
Shares of Meridian Biosciences rose 8 cents to $18.99 in afternoon trading.
Posted: December 2011